| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442117 | European Journal of Cancer | 2015 | 11 Pages |
Abstract
No differences in HRQoL and disease-specific symptoms were found between patients treated with SU versus SUÂ +Â adjCT in both younger and elderly colon cancer patients. Withholding patients adjCT, based on concerns for long-term HRQoL or disease-specific symptoms does therefore not seem plausible.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Simone Verhaar, Pauline A.J. Vissers, Huub Maas, Lonneke V. van de Poll-Franse, Felice N. van Erning, Floortje Mols,